362-OR: The Biological Variability of the BETA-2 Score in Islet Transplant Recipients

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 362-OR
Author(s):  
ROBYN MILLOTT ◽  
RICHARD A. ORAM ◽  
SHAREEN FORBES ◽  
A.M. JAMES SHAPIRO ◽  
PETER A. SENIOR ◽  
...  
Keyword(s):  
Biological Variability ◽  
Transplant Recipients ◽  
Islet Transplant ◽  
Beta 2

260-LB: Continuous Glucose Monitoring Metrics in Islet Transplant Recipients with Long-Term Insulin Independence

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 260-LB ◽  
Author(s):  
DAVID BAIDAL ◽  
ANA M. ALVAREZ GIL ◽  
NATHALIA PADILLA ◽  
CAMILLO RICORDI ◽  
RODOLFO ALEJANDRO
Keyword(s):  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Transplant Recipients ◽  
Insulin Independence ◽  
Islet Transplant

USE OF ACETAMINOPHEN LEVEL TESTING DURING MIXED MEAL STIMULATION IN ISLET TRANSPLANT RECIPIENTS USING EXENATIDE

2008 ◽  
Vol 86 (Supplement) ◽  
pp. 446
Author(s):  
T Froud ◽  
R N. Faradji ◽  
D A. Baidal ◽  
A Mendez ◽  
G Selvaggi ◽  
...  
Keyword(s):  
Transplant Recipients ◽  
Mixed Meal ◽  
Islet Transplant ◽  
Meal Stimulation

Humoral Immune Response following Seasonal Influenza Vaccine in Islet Transplant Recipients

2013 ◽  
Vol 22 (3) ◽  
pp. 469-476 ◽  
Author(s):  
Moacyr Silva ◽  
Atul Humar ◽  
A. M. James Shapiro ◽  
Peter Senior ◽  
Katja Hoschler ◽  
...  
Keyword(s):  
Immune Response ◽  
Influenza Vaccine ◽  
Humoral Immune Response ◽  
Seasonal Influenza ◽  
Transplant Recipients ◽  
Seasonal Influenza Vaccine ◽  
Islet Transplant ◽  
Humoral Immune

LATE EPSTEIN BARR VIRUS REACTIVATION IN ISLET TRANSPLANT RECIPIENTS

2008 ◽  
Vol 86 (Supplement) ◽  
pp. 443-444
Author(s):  
P Cure ◽  
C B. Leitao ◽  
A Pileggi ◽  
T Tharavanij ◽  
D A. Baidal ◽  
...  
Keyword(s):  
Epstein Barr Virus ◽  
Virus Reactivation ◽  
Transplant Recipients ◽  
Islet Transplant ◽  
Barr Virus ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation

Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients

2004 ◽  
Vol 36 (4) ◽  
pp. 1108-1110 ◽  
Author(s):  
A.O Gaber ◽  
D Fraga ◽  
M Kotb ◽  
A Lo ◽  
O Sabek ◽  
...  
Keyword(s):  
Clinical Response ◽  
Graft Function ◽  
Human Islet ◽  
Scid Mice ◽  
Islet Graft ◽  
Transplant Recipients ◽  
Islet Transplant

Clinical Use of Fructosamine in Islet Transplantation

2009 ◽  
Vol 18 (4) ◽  
pp. 453-458 ◽  
Author(s):  
Thipaporn Tharavanij ◽  
Tatiana Froud ◽  
Cristiane B. Leitao ◽  
David A. Baidal ◽  
Charlotte N. Paz-Pabon ◽  
...  
Keyword(s):  
Roc Analysis ◽  
Graft Function ◽  
Positive Association ◽  
Islet Graft ◽  
Transplant Recipients ◽  
Graft Dysfunction ◽  
Islet Transplant ◽  
Glucose Ratio ◽  
Capillary Glucose ◽  
Assay Interference

Many islet transplant recipients have medical conditions that could interfere with the accuracy of HbA1c measurements (e.g., anemia/dapsone use). Fructosamine is less prone to have clinical interferences and reflects glucose control in a shorter period of time than HbA1c. This study aimed to validate fructosamine use in islet transplant subjects and to evaluate its effectiveness as a predictor for islet graft dysfunction. Thirty-three islet transplant recipients who had concomitant fructosamine and HbA1c data available were retrospectively analyzed. HbA1c, fructosamine, mean capillary blood glucose, and islet graft function (fasting C-peptide/glucose ratio) were assessed. There was a significant and positive association between fructosamine and HbA1c ( p < 0.0001). Both variables were also positively associated with mean overall and fasting capillary glucose. Neither fructosamine nor HbA1c was shown by ROC analysis to significantly discriminate between periods with and without subsequent graft dysfunction. HbA1c >6% was predictive of this outcome 1 month in advance (OR 2.95, p = 0.003). However, although significantly associated with graft dysfunction, use of this cutoff as a predictor of dysfunction has poor sensitivity (50%) and specificity (77.6%). Fructosamine above the normal range (>270 μmol/L Quest Diagnostics) was also predictive of ensuing dysfunction (OR 2.47, p = 0.03); however, it had similarly poor sensitivity (62%) and specificity (64%). Fructosamine can be used as an alternative to HbA1c for glycemic assessment in islet transplant recipients in situations with HbA1c assay interference. Neither HbA1c nor fructosamine are good predictors of islet graft dysfunction.

scholarly journals Characterizing Donor‐Specific T Cells in Islet Transplant Recipients Using scRNA‐seq

2020 ◽  
Vol 34 (S1) ◽  
pp. 1-1
Author(s):  
Reed Fearing Trende ◽  
Sabarinathan Ramachandran ◽  
Bernhard Hering ◽  
Anders Matson
Keyword(s):  
T Cells ◽  
Transplant Recipients ◽  
Islet Transplant

scholarly journals Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Chris J. Callaghan ◽  
Lisa Mumford ◽  
Rebecca M. K. Curtis ◽  
Sarah V. Williams ◽  
Heather Whitaker ◽  
...  
Keyword(s):  
Real World ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Islet Transplant

SERUM BETA 2-MICROGLOBULIN MONITORING IN CYCLOSPORINE TREATED RENAL TRANSPLANT RECIPIENTS

1999 ◽  
Vol 67 (7) ◽  
pp. S82 ◽  
Author(s):  
Daniel P. Lange ◽  
Zachary C. Schmittling ◽  
Timothy P. O'Connor
Keyword(s):  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Beta 2 ◽  
Beta 2 Microglobulin
Sign in / Sign up

Export Citation Format

Share Document